Effects of cisplatin and tamoxifen chemotherapy on peri‐implant bone remodeling around titanium implants in ovariectomized rats: An in vivo study
Journal of Periodontology · 2026
DOI: 10.1002/jper.70096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Periodontology, 2026. Verfasst von Luiz G Fiorin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnosis and Surgery, São Paulo State University "Júlio de Mesquita Filho", UNESP, Araçatuba, Brazil. Hauptthemen laut MEDLINE: Tamoxifen, Bone Remodeling, Cisplatin, Dental Implants. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundação de Amparo á Pesquisa do Estado de São Paulo (FAPESP), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The proposition of the present study was to evaluate the influence of the secondary effect of tamoxifen (TAM) associated with cisplatin (CIS) in the bone remodeling of osseointegrated titanium implants installed in rat tibiae.
Methods
One hundred female rats underwent bilateral ovariectomy (OVX) and received titanium implants in both tibiae. Six weeks later, animals were treated with tamoxifen (15 mg/kg) or saline, with further subdivisions receiving cisplatin (5 mg/kg or 2.5 mg/kg) or saline. A non‐ovariectomized group served as a negative control. Animals were euthanized at 30 and 90 days after treatment initiation. Tibiae were harvested for histometric analysis of bone‐to‐implant contact (BIC) and bone ingrowth (BIN), histology, and immunohistochemistry (tartrate‐resistant acid phosphatase [TRAP], osteocalcin [OCN], and runt‐related transcription factor [RUNX2]). Additionally, scanning electron microscopy (SEM) and energy‐dispersive X‐ray spectroscopy (EDS) were used for ultrastructural and elemental analyses.
Results
The groups that received TAM showed higher BIC and BIN, increased expression of RUNX‐2 and OCN, and a lower number of TRAP‐positive cells. At 30 and 90 days, almost all spaces were filled with vital, well‐vascularized bone tissue without inflammatory foci. TAM groups also exhibited an increased calcium/phosphate (Ca/P) ratio compared to their respective controls, and a progressive thickening of collagen fibril bundles was observed in the bone matrix.
Conclusion
Tamoxifen positively influenced bone remodeling around osseointegrated titanium implants in rats undergoing cisplatin‐based cancer therapy. Plain language summary Dental implant surgery in patients undergoing chemotherapy is frequently approached with caution, as these pharmacological treatments can impair bone metabolism and jeopardize the integration of the implant with the bone. This study investigated whether tamoxifen, a medication widely utilized in breast cancer therapy, could potentially enhance bone healing around titanium implants, specifically when administered alongside the chemotherapeutic agent cisplatin. Utilizing a laboratory model that simulates postmenopausal bone loss, the research demonstrated that tamoxifen significantly improved both the volume and the structural quality of the bone surrounding the implants, partially mitigating the adverse effects associated with cisplatin. These findings are of clinical importance as they suggest that a history of chemotherapy should not be considered a definitive barrier to successful dental rehabilitation. Instead, with appropriate pharmacological support, dental implant procedures may be a more viable and predictable treatment option for cancer survivors than previously recognized. This research provides a foundation for clinicians to better evaluate the feasibility of oral rehabilitation in this patient population, ultimately aiming to improve their long‐term oral health and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnosis and Surgery, São Paulo State University "Júlio de Mesquita Filho", UNESP, Araçatuba, Brazil.
- School of Dentistry, Nucleus of Study and Research in Periodontics and Implantology (NEPPI), São Paulo State University (UNESP), Aracatuba, São Paulo, Brazil.
- Discipline of Periodontics, School of Dentistry, University of São Paulo, São Paulo, Brazil.
- Department of Basic Science, School of Dentistry, São Paulo State University (UNESP), Araçatuba, São Paulo, Brazil.
- Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.
- Thin Section Laboratory, Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano Statale (UNIMI), Milan, Italy.
ORCID-Profile: Luiz G Fiorin, Henrique Rinaldi Matheus, Gabriela Carrara Simionato, Ester Oliveira Santos, Francisley Avila Souza, Juliano M de Almeida
Förderung
- Fundação de Amparo á Pesquisa do Estado de São Paulo (FAPESP)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Fiorin, L. G., Rinaldi Matheus, H., Carrara Simionato, G., Santos, E. O., Delmonica Barra, R., Avila Souza, F., Ervolino, E., Dellavia, C., & de Almeida, J. M. (2026). Effects of cisplatin and tamoxifen chemotherapy on peri‐implant bone remodeling around titanium implants in ovariectomized rats: An in vivo study. Journal of Periodontology. https://doi.org/10.1002/jper.70096
Vancouver
Fiorin LG, Rinaldi Matheus H, Carrara Simionato G, Santos EO, Delmonica Barra R, Avila Souza F, et al. Effects of cisplatin and tamoxifen chemotherapy on peri‐implant bone remodeling around titanium implants in ovariectomized rats: An in vivo study. Journal of Periodontology. 2026. doi:10.1002/jper.70096
BibTeX
@article{Fiorin2026,
author = {Fiorin, Luiz G and Rinaldi Matheus, Henrique and Carrara Simionato, Gabriela and Santos, Ester Oliveira and Delmonica Barra, Ruan and Avila Souza, Francisley and Ervolino, Edilson and Dellavia, Claudia and de Almeida, Juliano M},
title = {Effects of cisplatin and tamoxifen chemotherapy on peri‐implant bone remodeling around titanium implants in ovariectomized rats: An in vivo study},
journal = {Journal of Periodontology},
year = {2026},
doi = {10.1002/jper.70096}
}
EUVIMED